Dustin J Randall1, Yue Zhang2, Haojia Li2, James C Hubbard3, Nikolas H Kazmers4. 1. Oakland University William Beaumont School of Medicine, Rochester, MI; Department of Orthopaedics, University of Utah, Salt Lake City, UT. 2. Division of Public Health, University of Utah, Salt Lake City, UT. 3. Department of Orthopaedics, University of Utah, Salt Lake City, UT. 4. Department of Orthopaedics, University of Utah, Salt Lake City, UT. Electronic address: nkazmers@gmail.com.
Abstract
PURPOSE: Although the pain visual analog scale (VAS-pain) is a ubiquitous patient-reported outcome instrument, it remains unclear how to interpret changes or differences in scores. Therefore, our purpose was to calculate the minimal clinically important difference (MCID) and substantial clinical benefit (SCB) for the VAS-pain instrument in a nonshoulder hand and upper extremity postoperative population. METHODS: Adult postoperative patients treated by 1 of 5 fellowship-trained orthopedic hand surgeons at a single tertiary academic medical center were identified. Inclusion required VAS-pain scores at baseline (up to 3 months before surgery) and follow-up (up to 4 months after surgery), in addition to a response to a pain-specific anchor question at follow-up. The MCID estimates were calculated with (1) the 1/2 standard deviation method; and (2) an anchor-based approach. The SCB estimates were calculated with (1) an anchor-based approach; and (2) a receiver operator curve method that maximized the sensitivity and specificity for detecting a "much improved" pain status. RESULTS: There were 667 and 148 total patients included in the MCID and SCB analyses, respectively. The 1/2 standard deviation MCID estimate was 1.6, and the anchor-based estimate was 1.9. The anchor-based SCB estimate was 2.2. The receiver operator curve analysis yielded an SCB estimate of 2.6, with an area under the curve of 0.72, consistent with acceptable discrimination. CONCLUSIONS: We propose MCID values in the range of 1.6 to 1.9 and SCB values in the range of 2.2 to 2.6 for the VAS-pain instrument in a nonshoulder hand and upper extremity postoperative population. CLINICAL RELEVANCE: These MCID and SCB estimates may be useful for powering clinical studies and when interpreting VAS-pain score changes or differences reported in the hand surgery literature. These values are to be applied at a population level, and should not be applied to assess the improvement, or lack thereof, for individual patients.
PURPOSE: Although the pain visual analog scale (VAS-pain) is a ubiquitous patient-reported outcome instrument, it remains unclear how to interpret changes or differences in scores. Therefore, our purpose was to calculate the minimal clinically important difference (MCID) and substantial clinical benefit (SCB) for the VAS-pain instrument in a nonshoulder hand and upper extremity postoperative population. METHODS: Adult postoperative patients treated by 1 of 5 fellowship-trained orthopedic hand surgeons at a single tertiary academic medical center were identified. Inclusion required VAS-pain scores at baseline (up to 3 months before surgery) and follow-up (up to 4 months after surgery), in addition to a response to a pain-specific anchor question at follow-up. The MCID estimates were calculated with (1) the 1/2 standard deviation method; and (2) an anchor-based approach. The SCB estimates were calculated with (1) an anchor-based approach; and (2) a receiver operator curve method that maximized the sensitivity and specificity for detecting a "much improved" pain status. RESULTS: There were 667 and 148 total patients included in the MCID and SCB analyses, respectively. The 1/2 standard deviation MCID estimate was 1.6, and the anchor-based estimate was 1.9. The anchor-based SCB estimate was 2.2. The receiver operator curve analysis yielded an SCB estimate of 2.6, with an area under the curve of 0.72, consistent with acceptable discrimination. CONCLUSIONS: We propose MCID values in the range of 1.6 to 1.9 and SCB values in the range of 2.2 to 2.6 for the VAS-pain instrument in a nonshoulder hand and upper extremity postoperative population. CLINICAL RELEVANCE: These MCID and SCB estimates may be useful for powering clinical studies and when interpreting VAS-pain score changes or differences reported in the hand surgery literature. These values are to be applied at a population level, and should not be applied to assess the improvement, or lack thereof, for individual patients.
Authors: Nikolas H Kazmers; Man Hung; Jerry Bounsanga; Maren W Voss; Abby Howenstein; Andrew R Tyser Journal: J Hand Surg Am Date: 2019-05-06 Impact factor: 2.230
Authors: Dorcas E Beaton; Dwayne van Eerd; Peter Smith; Gabrielle van der Velde; Kimberley Cullen; Carol A Kennedy; Sheilah Hogg-Johnson Journal: J Clin Epidemiol Date: 2010-12-15 Impact factor: 6.437
Authors: Brinkley Sandvall; Ugochi C Okoroafor; William Gerull; Jason Guattery; Ryan P Calfee Journal: J Hand Surg Am Date: 2019-04-04 Impact factor: 2.230
Authors: Amelia A Sorensen; Daniel Howard; Wen Hui Tan; Jeffrey Ketchersid; Ryan P Calfee Journal: J Hand Surg Am Date: 2013-03-06 Impact factor: 2.230
Authors: Steven D Glassman; Anne G Copay; Sigurd H Berven; David W Polly; Brian R Subach; Leah Y Carreon Journal: J Bone Joint Surg Am Date: 2008-09 Impact factor: 5.284
Authors: Nikolas H Kazmers; Yuqing Qiu; Zhining Ou; Angela P Presson; Andrew R Tyser; Yue Zhang Journal: J Hand Surg Am Date: 2021-01-09 Impact factor: 2.230
Authors: Nikolas H Kazmers; Yuqing Qiu; Minkyoung Yoo; Andrew R Stephens; Michelle Zeidan; Yue Zhang Journal: J Hand Surg Am Date: 2021-03-31 Impact factor: 2.342
Authors: Kari Kanto; Tuomas Lähdeoja; Mika Paavola; Pasi Aronen; Teppo L N Järvinen; Jarkko Jokihaara; Clare L Ardern; Teemu V Karjalainen; Simo Taimela Journal: BMC Med Res Methodol Date: 2021-03-06 Impact factor: 4.615